Medical News

RSS

Cook Medical introduces Otrieva Tapered Ovum Aspiration Needle

A new needle for ovum collection is now available to reproductive endocrinologists and embryologists: the Otrieva Tapered Ovum Aspiration Needle, which Cook Medical launches today. The Otrieva needle features a tapering process that results in a consistent bevel designed to allow precise ovum collection and less pain and bleeding during aspiration, as clinical studies of similar devices have demonstrated.

12 Sep 2011

Chromatin, Dow AgroSciences achieve first milestone in research collaboration

Chromatin Inc. announced today that they have reached the first milestone in their research collaboration with Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company. This collaboration is focused on developing a novel combination of Chromatin's Mini-Chromosomes with Dow AgroSciences' EXZACT Precision Technology.

12 Sep 2011

Alchemia initiates HA-Irinotecan Phase II clinical study in SCLC

Alchemia Limited, today announced the initiation of recruitment for a Phase II clinical study of its lead cancer drug HA-Irinotecan in Small Cell Lung Cancer (SCLC). Two patients have received their first doses of therapy. This investigator sponsored trial is being conducted at Monash Cancer Centre, Southern Health and Peninsula Oncology Centre in Melbourne, Victoria.

12 Sep 2011

Rug Doctor launches new Anti-Allergen Carpet Cleaner

Just in time for indoor allergy season, Rug Doctor, the manufacturer of the most convenient do-it-yourself hot water extraction carpet cleaning machines and products, has introduced a new Anti-Allergen Carpet Cleaner.

12 Sep 2011

Genentech submits NDA to FDA for vismodegib to treat advanced basal cell carcinoma

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking sales and marketing approval for vismodegib to treat people with advanced basal cell carcinoma (BCC), which includes metastatic and locally advanced BCC for whom surgery is inappropriate.

12 Sep 2011

Bruker to acquire Center for Tribology

Bruker Corporation today announced the signing of a purchase agreement to acquire Center for Tribology, Inc. (CETR) for an undisclosed amount.

12 Sep 2011

FDA clears Fujifilm's Aspire HD breast imaging system

Breast Imaging facilities looking for increased diagnostic confidence in mammography screening can now benefit from the exceptional image quality of the Aspire HD Full Field Digital Mammography (FFDM) system from FUJIFILM Medical Systems U.S.A., Inc. Now FDA 510(k) cleared, the Aspire HD provides image clarity that enables extraordinary detail of potential abnormalities that not only assists in more accurate and reliable diagnoses, but also results in enhanced clinician productivity.

12 Sep 2011

InterMune to launch Esbriet for German patients with IPF

InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.

12 Sep 2011

Genentech submits vismodegib NDA to FDA for treatment of advanced basal cell carcinoma

Genentech, a member of the Roche Group, today announced that the company has submitted a New Drug Application for vismodegib to the U.S. Food and Drug Administration (FDA) for the treatment of people with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.

12 Sep 2011

Valeritas completes Series C round of financing

Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, announced today it has completed a significant Series C round of financing of $150 million.

12 Sep 2011

IsoRay receives FDA clearance for GliaSite radiation therapy system to treat brain cancer

IsoRay, Inc. announced today that the FDA has cleared its GliaSite radiation therapy system, a balloon catheter device used in the treatment of brain cancer.

12 Sep 2011

Women with BRCA gene mutation develop breast cancer earlier than their ancestors

Women with a deleterious gene mutation are diagnosed with breast cancer almost eight years earlier than relatives of the previous generation who also had the disease and/or ovarian cancer, according to new research from The University of Texas MD Anderson Cancer Center.

12 Sep 2011

Researchers identify glucokinase triggers beta cell regeneration in pancreas

Researchers at the Hebrew University of Jerusalem have identified the key signal that prompts production of insulin-producing beta cells in the pancreas -- a breakthrough discovery that may ultimately help researchers find ways to restore or increase beta cell function in people with type 1 diabetes.

12 Sep 2011

ARC chooses Elsevier's SciVerse Scopus database for ERA 2012

Elsevier, a world-leading provider of scientific, technical and medical information products and services, is proud to announce the Australian Research Council has selected SciVerse Scopus, the world's largest abstract and citation database, for the third time as the sole citation provider for the Excellence in Research for Australia (ERA) assessment for 2012.

12 Sep 2011

Researchers discover that recognisable facial expressions develop before birth

Babies in the womb develop a range of facial movements in such a way that it is possible to identify facial expressions such as laughter and crying. For the first time a group of researchers were able to show that recognisable facial expressions develop before birth and that, as the pregnancy progresses from 24 to 36 weeks gestation, fetal facial movements become more complex.

12 Sep 2011

Tenet Healthcare refines 2011 Outlook for Adjusted EBITDA

In advance of scheduled investor meetings and the Company's participation at an industry conference, Tenet Healthcare Corporation today refined its 2011 Outlook for Adjusted EBITDA.

12 Sep 2011

BioClinica releases Express EDC solution for clinical trials

BioClinica, Inc., a global provider of clinical trial management solutions, announced the latest release of BioClinica Express EDC. This modern, web-based platform is a comprehensive electronic data capture (EDC) solution that adds speed and quality to every part of the clinical trial process.

From Clario 12 Sep 2011

Spinifex announces new data from EMA401 pre-clinical study on diabetic neuropathy

Spinifex Pharmaceuticals, an Australian pain drug development company, today announces the presentation of new data from a study of EMA401 in a model of diabetic neuropathy.

12 Sep 2011

Heart attack patients with psoriasis more likely to die from cardiovascular disease

Heart attack patients with psoriasis are 26 per cent more likely to die from cardiovascular disease, or suffer from recurrent heart attacks or strokes, and are 18 per cent more likely to die from all causes than those without the inflammatory skin disease.

12 Sep 2011

PHT announces availability of eDHP-18 QoL questionnaire on all ePRO collection modalities

PHT Corporation announced today the availability of the electronic version of the DHP-18 (Diabetes Health Profile) Quality of Life (QoL) questionnaire on all of its electronic patient reported outcome (ePRO) collection modalities - smartphone, tablet and Web. PHT is the global pacesetter in PRO and ePRO solutions that maximize the collection of high-quality data from clinical trial patients to improve clinical trial efficiencies.

12 Sep 2011